Vascular  ||| S:0 E:9 ||| JJ
lasers  ||| S:9 E:16 ||| NNS
After  ||| S:16 E:22 ||| IN
reviewing  ||| S:22 E:32 ||| VBG
the  ||| S:32 E:36 ||| DT
main  ||| S:36 E:41 ||| JJ
technical  ||| S:41 E:51 ||| JJ
features  ||| S:51 E:60 ||| NNS
of  ||| S:60 E:63 ||| IN
the  ||| S:63 E:67 ||| DT
lasers  ||| S:67 E:74 ||| NNS
and  ||| S:74 E:78 ||| CC
flashlamps  ||| S:78 E:89 ||| VBP
currently  ||| S:89 E:99 ||| RB
available ||| S:99 E:108 ||| JJ
,  ||| S:108 E:110 ||| ,
the  ||| S:110 E:114 ||| DT
indications  ||| S:114 E:126 ||| NNS
for  ||| S:126 E:130 ||| IN
these  ||| S:130 E:136 ||| DT
devices  ||| S:136 E:144 ||| NNS
are  ||| S:144 E:148 ||| VBP
detailed ||| S:148 E:156 ||| VBN
,  ||| S:156 E:158 ||| ,
mainly  ||| S:158 E:165 ||| RB
port  ||| S:165 E:170 ||| JJ
wine  ||| S:170 E:175 ||| NN
stains ||| S:175 E:181 ||| NNS
,  ||| S:181 E:183 ||| ,
facial  ||| S:183 E:190 ||| JJ
telangiectasia ||| S:190 E:204 ||| NN
,  ||| S:204 E:206 ||| ,
hemangiomas ||| S:206 E:217 ||| NN
,  ||| S:217 E:219 ||| ,
and  ||| S:219 E:223 ||| CC
lower-limb  ||| S:223 E:234 ||| JJ
varicosities ||| S:234 E:246 ||| NN
.  ||| S:246 E:248 ||| .
Respecting  ||| S:248 E:259 ||| VBG
the  ||| S:259 E:263 ||| DT
principles  ||| S:263 E:274 ||| NNS
of  ||| S:274 E:277 ||| IN
treatment  ||| S:277 E:287 ||| NN
( ||| S:287 E:288 ||| -LRB-
briefly  ||| S:288 E:296 ||| FW
reviewed  ||| S:296 E:305 ||| FW
herein ||| S:305 E:311 ||| FW
) ||| S:311 E:312 ||| -RRB-
,  ||| S:312 E:314 ||| ,
contributes  ||| S:314 E:326 ||| VBZ
to  ||| S:326 E:329 ||| TO
preventing  ||| S:329 E:340 ||| VBG
complications ||| S:340 E:353 ||| NNS
,  ||| S:353 E:355 ||| ,
which  ||| S:355 E:361 ||| WDT
are  ||| S:361 E:365 ||| VBP
consequently  ||| S:365 E:378 ||| RB
becoming  ||| S:378 E:387 ||| VBG
rare ||| S:387 E:391 ||| JJ
.  ||| S:391 E:393 ||| .
